Alzheimer's Drug Discovery Foundation $150,000-$600,000 based on stage and scope of research. Larger amounts will be considered for PET ligand development for regulatory or clinical work. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged. Letter of Intent, July 12, 2019, Invited Full Proposal, August 9, 2019; Letter of Intent, October 11, 2019, Invited Full Proposal, November 8, 2019. Neuroimaging and CSF Biomarket Development Program

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.